Enanta Pharmaceuticals Inc (ENTA)
R&D Expenses
$86.24M
TTM · Period ending: · USD
ENTA R&D Expenses
Latest reported$86.24Mperiod ending
Latest reported$86.24Mperiod ending
ENTA TTM R&D Expenses ($17.24M → $86.24M)
TTM R&D Expenses
High-resolution chart · PNG
ENTA r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 86,237,000 | |
| 91,321,000 | |
| 99,943,000 | |
| 106,740,000 | |
| 113,709,000 | |
| 115,241,000 | |
| 122,761,000 | |
| 131,476,000 | |
| 136,865,000 | |
| 151,110,000 | |
| 158,993,000 | |
| 163,524,000 | |
| 162,153,000 | |
| 158,256,000 | |
| 156,875,000 | |
| 164,522,000 | |
| 178,672,000 | |
| 186,576,000 | |
| 185,995,000 | |
| 174,111,000 | |
| 161,851,000 | |
| 149,539,000 | |
| 140,643,000 | |
| 136,756,000 | |
| 138,789,000 | |
| 138,568,000 | |
| 140,113,000 | |
| 142,213,000 | |
| 130,417,000 | |
| 124,443,000 | |
| 111,772,000 | |
| 94,856,000 | |
| 84,447,000 | |
| 71,367,000 | |
| 62,887,000 | |
| 57,451,000 | |
| 52,437,000 | |
| 47,815,000 | |
| 43,954,000 | |
| 40,461,000 | |
| 36,010,000 | |
| 31,478,000 | |
| 27,703,000 | |
| 23,189,000 | |
| 21,342,000 | |
| 19,642,000 | |
| 18,996,000 | |
| 18,740,000 | |
| 17,838,000 | |
| 17,324,000 | |
| 16,457,000 | |
| 16,992,000 | |
| 16,947,000 | |
| 17,833,000 | |
| 17,241,000 | |
| 15,115,000 | |
| 13,789,000 |